Scopus BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Cash & Equivalents	0.36	0.12	7.94	1.83	0.04	0
Cash & Short-Term Investments	0.36	0.12	7.94	1.83	0.04	0
Cash Growth	-68.69%	-98.43%	333.54%	4885.71%	2113.67%	-98.95%
Other Receivables	-	-	-	-	-	0.03
Receivables	-	-	-	-	-	0.03
Prepaid Expenses	0.13	0.27	0.24	0.14	0.08	0.1
Other Current Assets	-	-	-	-	0.65	-
Total Current Assets	0.5	0.39	8.18	1.97	0.77	0.13
Property, Plant & Equipment	0	0	0	0	0	-
Total Assets	0.5	0.39	8.19	1.97	0.77	0.13
Accounts Payable	0.17	0.18	0.12	0.09	0.16	-
Accrued Expenses	10.74	7.03	4.05	1.43	0.69	0.11
Current Portion of Long-Term Debt	-	-	-	2.28	-	-
Other Current Liabilities	0.09	0.25	-	-	-	0.02
Total Current Liabilities	11	7.45	4.17	3.81	0.85	0.14
Total Liabilities	11	7.45	4.17	3.81	0.85	0.14
Common Stock	0.04	0.02	0.02	0.01	0.01	0.01
Additional Paid-In Capital	48.62	46.52	45.54	14.22	3.58	0.94
Retained Earnings	-58.13	-53.06	-41.46	-14.5	-3.64	-0.95
Comprehensive Income & Other	0.02	-0.04	-0.09	-1.57	-0.03	-0.01
Total Common Equity	-9.45	-6.56	4.02	-1.83	-0.08	-0.01
Minority Interest	-1.05	-0.5	-	-	-	-
Shareholders' Equity	-10.5	-7.06	4.02	-1.83	-0.08	-0.01
Total Liabilities & Equity	0.5	0.39	8.19	1.97	0.77	0.13
Total Debt	-	-	-	2.28	-	-
Net Cash (Debt)	0.36	0.12	7.94	-0.45	0.04	0
Net Cash Growth	-68.69%	-98.43%	-	-	2113.67%	-98.95%
Net Cash Per Share	0.01	0.01	0.46	-0.03	0.00	0.00
Filing Date Shares Outstanding	42.08	39.58	21.09	15.73	12.51	10.77
Total Common Shares Outstanding	39.78	21.09	21.09	14.58	12.51	10.77
Working Capital	-10.51	-7.06	4.01	-1.83	-0.09	-0.01
Book Value Per Share	-0.24	-0.31	0.19	-0.13	-0.01	-0.00
Tangible Book Value	-9.45	-6.56	4.02	-1.83	-0.08	-0.01
Tangible Book Value Per Share	-0.24	-0.31	0.19	-0.13	-0.01	-0.00

Updated Aug 11, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.